The flavoenzyme nikD is required for the biosynthesis of nikkomycin antibiotics. NikD exhibits an unusual long wavelength absorption band attributed to a charge transfer complex of FAD with an unknown charge transfer donor. NikD crystals contain an endogenous active site ligand. At least four different compounds are detected in nikD extracts, including variable amounts of two ADP derivatives that bind to the enzyme's dinucleotide binding motif in competition with FAD, picolinate (0.07 mol/mol nikD) and an unknown picolinate-like compound. Picolinate, the product of the physiological catalytic reaction, matches the properties deduced for the active site ligand in nikD crystals. The charge transfer band is eliminated upon mixing nikD with excess picolinate but not by a reversible unfolding procedure that removes the picolinate-like compound, ruling out both compounds as the intrinsic charge transfer donor. Mutation of Trp355 to Phe eliminates the charge transfer band, accompanied by a 30-fold decrease in substrate binding affinity. The results provide definitive evidence for Trp355 as the intrinsic charge transfer donor. The indole ring of Trp355 is coplanar with or perpendicular to the flavin ring in "open" or "closed" crystalline forms of nikD, respectively. Importantly, a coplanar configuration is required for charge transfer interaction. Absorption in the long wavelength region therefore constitutes a valuable probe to monitor conformational changes in solution that are likely to be important in nikD catalysis.Nikkomycins are peptidyl nucleoside antibiotics that block the biosynthesis of chitin by inhibiting chitin synthase (1). Chitin, the second most abundant polysaccharide in nature, maintains the structural integrity of the cell wall in fungi and the exoskeleton of insects and other invertebrates. Neither chitin nor chitin synthase is found in mammals. Nikkomycins are effective for the therapeutic treatment of fungal infections in humans and as easily degraded insecticides in agriculture (2).Biosynthesis of the nikkomycin peptide occurs via a nonribosomal pathway. The first step is catalyzed by an aminotransferase that converts L-lysine to an α-keto intermediate that cyclizes and dehydrates to yield piperideine-2-carboxylate (P2C), a compound that can exist in imine and enamine forms (3). The second step is catalyzed by nikD in a reaction that involves a remarkable 4-electron oxidation of P2C to picolinate, accompanied by reduction of 2 mol of oxygen to hydrogen peroxide (Scheme 1) (4-6). NikD contains 1 mol of covalently bound FAD (8″-S-cysteinyl-FAD), exists as a monomer in solution and acts as an obligate 2-electron acceptor. The initial 2-electron oxidation of P2C to dihydropicolinate (DHP) is rate- † This work was supported in part by Grant AI 55590 (M. S. J.) from the National Institutes of Health.*To whom correspondence should be addressed. Phone: (215) NikD exhibits two absorption maxima in the visible region, a feature characteristic of flavincontaining enzymes. However, the enzyme also ...